<qa>  What is the purpose of the test?The purpose is to test the efficacy and safety of demcizumab, when given in combination with gemcitabine and Abraxane compared to placebo. The administration of gemcitabine and Abraxane is a standard treatment for patients with metastatic pancreatic ductal adenocarcinoma. 